Toronto Dominion Bank
TVGNW icon

Toronto Dominion Bank’s Tevogen Bio Warrant TVGNW Stock Holding History

Toronto Dominion Bank’s Portfolio TVGNW Stock Details TVGNW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3 Buy
+100
New +$4 ﹤0.01% 2087

Other funds holding TVGNW

FCM
FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $28.2B AUM 21.78% 1-Year Est. Return
Parallax Volatility Advisers
Parallax Volatility Advisers San Francisco, California $38.6B AUM 45.89% 1-Year Est. Return
GCM
Greenland Capital Management New York $787M AUM 40.68% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

Toronto Dominion Bank's TVGNW Position: Q1 2026 in Review

Toronto Dominion Bank opened a new position in Tevogen Bio Warrant (TVGNW) in Q1 2026: 100 shares worth $3. The stake represents ﹤0.01% of the portfolio and ranks #2087 among its holdings.

33 funds tracked by Wall St. Rank hold TVGNW as of Q1 2026.

  • Toronto Dominion Bank held 100 shares of Tevogen Bio Warrant worth $3 as of Q1 2026.
  • Tevogen Bio Warrant was a new Toronto Dominion Bank position in Q1 2026.
  • Tevogen Bio Warrant made up ﹤0.01% of Toronto Dominion Bank's portfolio in Q1 2026, its #2087 holding.
  • 33 funds tracked by Wall St. Rank held Tevogen Bio Warrant as of Q1 2026.

Based on Toronto Dominion Bank's 13F filing for Q1 2026, filed 15 May 2026.